Shares of Hims & Hers tumble 21% after FDA says semaglutide is no longer in shortage
Related Posts
OpenAI restructure plan gets SoftBank blessing as AI startup reportedly renegotiates Microsoft terms
The SoftBank CFO said OpenAI’s planned restructuring with the nonprofit keeping control is something that was expected.
Why Trump’s economic policies may have cancelled the DOGE dividend check, at least for now
The market is wobbling and inflation will be back if Trump follows through on tariffs threats on April 2. Would a DOGE dividend check hurt […]
Stocks making the biggest moves premarket: Charter Communications, Doximity, Novo Nordisk and more
These are the stocks posting the largest moves in premarket trading.